Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 36.5%, free cash flow fell 174.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

391.98 12.81 −3.16%
Market cap
$58.4B
P/E
0.0×
Fwd P/E
−130×
Dividend yield
—
F-score
6/9
Altman Z
26.84
Beneish M
−2.17
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 6 6 6
ROE
(29.02%) (14.32%) (15.02%) (12.54%)
ROA
(18.12%) (10.26%) (10.41%) (8.71%)
ROIC
(75.81%) (27.03%) (26.44%) (22.34%)
Return on Tangible Assets
(25.51%) (16.05%) (16.60%) (13.51%)
Average Days of Receivables
49.38 46.93 60.95 56.89
Free Cash Flow per Share
0.77 0.80 0.74 0.59
Free Cash Flow
106.07 109.11 104.51 84.20
Other line items

Show all line items

Columns are period end dates